Clinical Trials Logo

Filter by:
NCT ID: NCT04930250 Completed - Healthy Clinical Trials

Effect of Various Processed Oat Bran in a Beverage Matrix on Glycaemic Health

Start date: July 19, 2021
Phase: N/A
Study type: Interventional

Whilst a cause-and-effect relationship between consumption of oat ß-glucans and reduction in PPGR has been demonstrated, little is understood about its: - Application to liquid matrices: There are few studies which looked into the effect of a dose of ß-glucan applicable to beverages. Previous studies have explored oat ß-glucan doses between 2g to 13g per serving of test product (Note: the oat ß-glucan dose for the proposed trial is <2g). - Impact following processing: Collectively, oat processing, ß-glucan structure and its physiological impact on PPGR are closely linked. Some studies have investigated the effect of oat processing or dosage on PPGR, but to our knowledge, no study has systematically characterised the effect of processing on oat structure, and clinically measured its subsequent impact on PPGR.

NCT ID: NCT04927026 Completed - Mental Health Clinical Trials

"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults

Start date: September 1, 2019
Phase: N/A
Study type: Interventional

The World Health Organization (WHO) reported that approximately 15% of adults aged 60 and above suffer from some form of mental disorder, with one of the most common neuropsychiatric disorders being depression. Similar trends are seen in Singapore where 11.4% of the older adults aged 65 and above had depressive symptoms. Another population survey conducted among elderly in Singapore showed that elderly with subsyndromal depression (SSD) were similar to or worse than elderly with Major Depressive Disorder (MDD). However being a multi-ethnic Asia society the mental conditions such as depression and anxiety are seen as taboo topics to be discussed more so to seek help or treatment for these conditions in Singapore. Additionally scarcity of trained psychiatrists and work load of these trained professionals in the acute care settings make it difficult to reach these needy older adults. Hence, it is imperative to support the needs of this group of community dwelling older adults to ensure that their emotional wellbeing, and their condition do not progress to MDD. As such, this is the first of its kind study that will evaluate the effectiveness of solution focused brief therapy delivered by the lay mindfulness practitioner and the nurses. If the pilot intervention is found to be feasible and effective, the large scale community trial will be planned to reach to more elderly in Singapore to help them age in a dignified way. In addition, other countries that do not involve lay mindfulness practitioners and nurses to provide integrated personal therapy in the community may benefit from this study as well.

NCT ID: NCT04923269 Completed - Healthy Clinical Trials

A Study of LY3532226 in Healthy Participants

Start date: June 10, 2021
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of the study drug known as LY3532226 in healthy participants. Blood tests will be performed to check how much LY3532226 gets into the bloodstream and how long it takes the body to eliminate it. This study will last approximately 8 weeks including screening period.

NCT ID: NCT04917094 Completed - Clinical trials for Obstructive Sleep Apnea

Effectiveness of Compression Stocking on Overnight Fluid Shift in Obstructive Sleep Apnoea Patients

Start date: August 28, 2021
Phase: N/A
Study type: Interventional

Overnight rostral fluid shift is one of the contributing factors for worsening obstructive sleep apnoea (OSA). Fluid shift has been recognized to play a role in the pathophysiology of sleep apnoea. Previous studies shown that fluid from the leg redistributes to the neck at night increases the neck circumference, hence indicating fluid accumulation in the neck. OSA patients are more susceptible to developing upper airway narrowing in response to fluid shift from the leg to the head and neck region. Previous studies were mainly done on Caucasian patients. The pathophysiology of OSA in Caucasian patients and Asian patients are different but both suffer a similar degree of OSA. The investigators would like to investigate if reducing leg swelling by a simple non-invasive intervention of wearing compression stocking during the day can attenuate sleep apnoea, and whether compression stocking is generally acceptable and well-tolerated among the general OSA population in Asia.

NCT ID: NCT04914572 Completed - Anxiety Clinical Trials

Therapeutic Rainforest Study in Generating Positive Energy Among Undergraduate Students

Start date: August 31, 2021
Phase: N/A
Study type: Interventional

This study looked into how therapeutic forest walking will impact the well-being of undergraduate students at the National University of Singapore. A three-arm randomized control trial on 108 participants is being planned for this study. The primary aim of this study is to assess the feasibility and primary effect of the Therapeutic Rainforest Walking in generating positive energy among undergraduate students project in enhancing the quality of life, physical, mental, and psycho-social well-being among University students.

NCT ID: NCT04914546 Completed - Healthy Clinical Trials

A Study of LY3819469 in Healthy Participants

Start date: June 14, 2021
Phase: Phase 1
Study type: Interventional

This is a 2-part study. In Part A, the main purpose is to evaluate the safety and tolerability of the study drug LY3819469 in healthy participants with high lipoprotein (a) [Lp(a)] levels. How the body processes the study drug and the effect of the study drug on blood Lp(a) levels will also be investigated. Part B will mainly evaluate the safety and tolerability of LY3819469 as well as how the body processes the study drug in Japanese participants. The study may last up to 53 and 29 weeks for each participant in Parts A and B, respectively.

NCT ID: NCT04911803 Completed - Anxiety and Worry Clinical Trials

Self-help App and Wellbeing

Start date: June 8, 2021
Phase: N/A
Study type: Interventional

Anxiety and worry are amongst the most common mental health difficulties. The Second Mental Health Study found a significant increase in the lifetime prevalence for GAD, from 0.9% to 1.6%. In addition, the Organisation for Economic Cooperation and Development found that among Singaporean students, 86% experienced anxiety levels that were significantly higher than the OECD average. Past research revealed that individuals who worried more experienced decreases in life satisfaction. It was also found that worry and anxiety are significant predictors of one's psychological wellbeing . In line with this trend, the market for wellbeing apps have been one of the fastest growing categories of apps ever since; with more than 10,000 on the market. Studies have shown that the use of wellbeing apps has been correlated with an improvement in mental wellbeing. However, due to the lack of research that focuses on disorder-specific evidence, there still exists debates around the effectiveness of wellbeing apps on anxiety and worry. In addition, the lack of research on the mediating factor of psychological mindedness in the relationship between the use of wellbeing apps and mental well-being, could be pivotal to the effectiveness of wellbeing apps. To show the effectiveness of evidence-based wellbeing apps in targeting anxiety and worry, this study will employ the engagement of participants with a wellbeing app for a controlled period of 2 weeks before recording their mental wellbeing outcomes.This paradigm has been replicated extensively through multiple studies. This study will use a between-groups experimental study design whereby participants will be block randomised into 2 conditions: Active control condition, and Anxiety condition. Each condition will be given a restricted version of the wellbeing app according to their treatment groups. Follow-up data will be collected at 2-weeks post intervention to establish efficacy of the intervention. Objective 1: To evaluate the effectiveness of a wellbeing app self-help programme for reducing anxiety and worry. Objective 2: To examine if psychological mindedness moderates hypothesised effects of wellbeing app usage and anxiety and worry. Hypothesis 1: Participants in the intervention group will report significantly lower anxiety and worry than participants in the control group. Hypothesis 2: Psychological mindedness will moderate the effect of the wellbeing app's self-help programme on anxiety and worry: Participants high in psychological mindedness will benefit more from the wellbeing apps than those with lower scores on psychological mindedness.

NCT ID: NCT04897867 Completed - Clinical trials for Non-invasive Fat Reduction

CoolSculpting® Elite for Non-Invasive Fat Reduction

Start date: May 18, 2021
Phase: Phase 4
Study type: Interventional

This study aims to generate data that conveys participant's experiences such as their satisfaction with treatment delivered by the redesigned CoolSculpting® Elite system for non-invasive fat reduction in the midsection area (abdomen and flanks) in addition to optional body areas of upper arms, inner thighs, outer thighs and/or submental area. By doing this, the study will provide insights for doctors to better inform participants about the expected outcomes when one or more body areas are considered for treatment.

NCT ID: NCT04878380 Completed - Sleep Clinical Trials

hiSG Sleep Health Study

hiSG-SHS
Start date: August 15, 2021
Phase: N/A
Study type: Interventional

The hiSG Sleep Health Study seeks to investigate the efficacy of education + goal-based programmes for the promotion of healthy sleep habits and to evaluate its impact on daytime sleepiness and mental health.

NCT ID: NCT04877366 Completed - Dietary Supplement Clinical Trials

Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia

Stardust
Start date: July 21, 2021
Phase: N/A
Study type: Interventional

This is a mechanistic, single-center, double-blind, placebo- and active-controlled, three-time-period, crossover study to evaluate the effect of sprinkled format REDUCOSE compared to placebo (double-blind; confirmative) and active control (open-label; acarbose - explorative) on post prandial glycemia in Asian patients with type 2 diabetes.